Zevra Therapeutics, Inc. (ZVRA)
$11.00-0.72%Close
SELLRECOVERY · day 2
Key stats
Short interest · FINRA settlement 2026-09-15
- Market cap
- $650M
- Beta
- 0.98
- P/E (TTM)
- 11.17
- Short % float
- 10.45%
- Days to cover
- 6.3
- SI change
- -0.6%
- 1W
- +8.06%
- 1M
- -8.64%
- vs SPY 1W
- +6.50%
- vs SPY 1M
- -10.40%
Industry peers
FMP comparable companies · ranked by market cap
- NBIXSELLNeurocrine Biosciences, Inc.$14.6BRECOVERYQ 17$145.51-1.55%
- JAZZSELLJazz Pharmaceuticals plc$14.5BBEARQ 24$231.39-3.78%
- PRAXSELLPraxis Precision Medicines, Inc.$7.8BCRISISQ 11$280.14-5.20%
- ALKSSELLAlkermes plc$7.0BRECOVERYQ 6$41.65-3.23%
- XENESELLXenon Pharmaceuticals Inc.$3.5BCRISISQ 22$36.57-0.69%
- SUPNBUYSupernus Pharmaceuticals, Inc.$2.5BRECOVERYQ 26$42.83-2.11%
- GHRSSELLGH Research PLC$1.5BCRISISQ 15$21.52-2.90%
- ANROSELLAlto Neuroscience, Inc.$831MCRISISQ 17$23.69+2.17%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
